Position in ALVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$40
+$3 QoQ
Shares Held
11
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 72 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Zurcher Kantonalbank (Zurich Cantonalbank) holds $123,850,439 across 36 Drug Manufacturers - Specialty & Generic names. ALVO ranks #34 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
51,700 | $28,012,611 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
140,854 | $23,739,533 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
694,126 | $23,516,988 | |
| 4 | VTRS |
Viatris Inc
|
668,826 | $10,620,956 | |
| 5 | ZTS |
Zoetis Inc.
|
125,452 | $9,014,980 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
225,330 | $5,545,371 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
30,555 | $3,389,771 | |
| 8 | ALKS |
Alkermes plc.
|
61,584 | $3,227,001 |
All Filings in ALVO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $40 | 11 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $37 | 11 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,001 | 585 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $4,791 | 585 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,907 | 867 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $9,931 | 1,027 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||